Intrinsic Value of S&P & Nasdaq Contact Us

Assertio Holdings, Inc. ASRT NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
31/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.38
-86.8%

Assertio Holdings, Inc. (ASRT) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 8 Buy, 9 Hold, 1 Sell.

The consensus price target is $2.38 (low: $1.75, high: $3.00), representing a downside of 86.8% from the current price $18.02.

Analysts estimate Earnings Per Share (EPS) of $-2.37 and revenue of $0.12B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.23 vs est $-2.37 (beat +90.3%). 2025: actual $-4.74 vs est $-5.99 (beat +20.9%). Analyst accuracy: 0%.

ASRT Stock — 12-Month Price Forecast

$2.38
▼ -86.79% Downside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for Assertio Holdings, Inc., the average price target is $2.38, with a high forecast of $3.00, and a low forecast of $1.75.
The average price target represents a -86.79% change from the last price of $18.02.
Highest Price Target
$3.00
Average Price Target
$2.38
Lowest Price Target
$1.75

ASRT Analyst Ratings

Hold
18
Ratings
8 Buy
9 Hold
1 Sell
Based on 18 analysts giving stock ratings to Assertio Holdings, Inc. in the past 3 months
Rating breakdown
Buy
8 44%
Hold
9 50%
Sell
1 6%
44%
Buy
8 analysts
50%
Hold
9 analysts
6%
Sell
1 analysts

EPS Estimates — ASRT

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.23 vs Est –$2.37 ▲ 930.4% off
2025 Actual –$4.74 vs Est –$5.99 ▲ 26.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — ASRT

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.125B vs Est $0.121B ▲ 2.8% off
2025 Actual $0.119B vs Est $0.111B ▲ 6.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message